Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence

Background The behavioural impact of pharmacogenomics is untested; informing smokers of genetic test results for responsiveness to smoking cessation medication may increase adherence to this medication. The objective of this trial is to estimate the impact upon adherence to nicotine replacement ther...

Full description

Saved in:

Bibliographic Details
Published in:	BMC public health Vol. 10; no. 1; p. 680
Main Authors:	Marteau, Theresa M, Munafò, Marcus R, Aveyard, Paul, Hill, Chloe, Whitwell, Sophia, Willis, Thomas A, Crockett, Rachel A, Hollands, Gareth J, Johnstone, Elaine C, Wright, Alison J, Prevost, A Toby, Armstrong, David, Sutton, Stephen, Kinmonth, Ann Louise
Format:	Journal Article
Language:	English
Published:	London BioMed Central 09.11.2010 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	Adult Biostatistics Biotechnology industry College campuses Communication Deoxyribonucleic acid DNA England Environmental Health Epidemiology Ganglionic Stimulants - administration & dosage Genetic aspects Genetic screening Genetic testing Genotype Genotype & phenotype Health care Health psychology Health sciences Humans Medical research Medicine Medicine & Public Health Molecular Targeted Therapy Nicotine Nicotine - administration & dosage No confidence motions & votes Patient Compliance Prescriptions Preventive medicine Primary care Public Health Receptors, Opioid, mu - genetics Research Design Smoking Smoking - drug therapy Smoking Cessation Smoking cessation products Smoking cessation programs State Medicine Study Protocol Surveys and Questionnaires Vaccine England United Kingdom National Health Service Nicotine Dependence Nicotine Replacement Therapy Nicotine Smoking Cessation
ISSN:	1471-2458, 1471-2458
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!